Designing development programs for non-traditional antibacterial agents.
Nat Commun. 2019.
PMID: 31366924
Free PMC article.
Review.
Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2019 | 1 |
| 2023 | 1 |
Search Results
2 results
Results by year
Citations
1 article found by citation matchingSearch results
Filters applied: . Clear all
Page 1
Designing development programs for non-traditional antibacterial agents.
Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K.
Rex JH, et al.
Nat Commun. 2019 Jul 31;10(1):3416. doi: 10.1038/s41467-019-11303-9.
Nat Commun. 2019.
PMID: 31366924
Free PMC article.
Review.
In the face of rising rates of antibacterial resistance, many responses are being pursued in parallel, including 'non-traditional' antibacterial agents (agents that are not small-molecule drugs and/or do not act by directly targeting b …
In the face of rising rates of antibacterial resistance, many responses are being pursued in parallel, including 'non-tradi …
Item in Clipboard
Antibiotics in the clinical pipeline as of December 2022.
Butler MS, Henderson IR, Capon RJ, Blaskovich MAT.
Butler MS, et al.
J Antibiot (Tokyo). 2023 Aug;76(8):431-473. doi: 10.1038/s41429-023-00629-8. Epub 2023 Jun 8.
J Antibiot (Tokyo). 2023.
PMID: 37291465
Free PMC article.
Review.
The need for new antibacterial drugs to treat the increasing global prevalence of drug-resistant bacterial infections has clearly attracted global attention, with a range of existing and upcoming funding, policy, and legislative initiatives designed to revive …
The need for new antibacterial drugs to treat the increasing global prevalence of drug-resistant bacterial infections has clea …
Item in Clipboard
Cite
Cite